Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|22|3222-3234

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.22, 2012-07, pp. : 3222-3234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Iron Chelation in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 10, Iss. 12, 2003-06 ,pp. : 1021-1034

Bentham Science Publishers

Access to resources Recommend Favorite

ICL 670: effective oral iron chelation therapy

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Update on Clinical, Pathophysiological and Therapeutic Aspects in ANCAAssociated Vasculitides

By  

Current Drug Discovery Technologies, Vol. 6, Iss. 4, 2009-12 ,pp. : 241-251

Bentham Science Publishers

Access to resources Recommend Favorite

Forms of Iron Binding in the Cells and the Chemical Features of Chelation Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 9, 2009-08 ,pp. : 1136-1146

Bentham Science Publishers

Access to resources Recommend Favorite

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

By Kontoghiorghes G J   Kolnagou A   Peng C-T   Shah S V   Aessopos A  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 201-206

Informa Healthcare

Access to resources Recommend Favorite